These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 25684235)
1. Late gadolinium enhancement on cardiac magnetic resonance represents the depolarizing and repolarizing electrically damaged foci causing malignant ventricular arrhythmia in hypertrophic cardiomyopathy. Sakamoto N; Kawamura Y; Sato N; Nimura A; Matsuki M; Yamauchi A; Kanno T; Tanabe Y; Takeuchi T; Natori S; Saijo Y; Aburano T; Hasebe N Heart Rhythm; 2015 Jun; 12(6):1276-84. PubMed ID: 25684235 [TBL] [Abstract][Full Text] [Related]
2. Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia. Sakamoto N; Sato N; Oikawa K; Karim Talib A; Sugiyama E; Minoshima A; Tanabe Y; Takeuchi T; Akasaka K; Saijo Y; Kawamura Y; Hasebe N Heart Rhythm; 2015 Aug; 12(8):1747-55. PubMed ID: 25916568 [TBL] [Abstract][Full Text] [Related]
3. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699 [TBL] [Abstract][Full Text] [Related]
4. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study. Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853 [TBL] [Abstract][Full Text] [Related]
5. Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy. Spinner JA; Noel CV; Denfield SW; Krishnamurthy R; Jeewa A; Dreyer WJ; Maskatia SA Am J Cardiol; 2016 Apr; 117(8):1342-8. PubMed ID: 26892450 [TBL] [Abstract][Full Text] [Related]
7. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia. Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900 [TBL] [Abstract][Full Text] [Related]
8. T-wave inversions related to left ventricular basal hypertrophy and myocardial fibrosis in non-apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance imaging study. Chen X; Zhao S; Zhao T; Lu M; Yin G; Jiang S; Prasad S Eur J Radiol; 2014 Feb; 83(2):297-302. PubMed ID: 24332848 [TBL] [Abstract][Full Text] [Related]
9. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias. Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142 [TBL] [Abstract][Full Text] [Related]
10. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428 [TBL] [Abstract][Full Text] [Related]
11. Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction. Zhu Y; Park EA; Lee W; Kim HK; Chu A; Chung JW; Park JH Eur Radiol; 2015 Apr; 25(4):1190-200. PubMed ID: 25597022 [TBL] [Abstract][Full Text] [Related]
12. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. Fluechter S; Kuschyk J; Wolpert C; Doesch C; Veltmann C; Haghi D; Schoenberg SO; Sueselbeck T; Germans T; Streitner F; Borggrefe M; Papavassiliu T J Cardiovasc Magn Reson; 2010 May; 12(1):30. PubMed ID: 20492668 [TBL] [Abstract][Full Text] [Related]
13. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy. Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040 [TBL] [Abstract][Full Text] [Related]
14. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype. Ellims AH; Iles LM; Ling LH; Chong B; Macciocca I; Slavin GS; Hare JL; Kaye DM; Marasco SF; McLean CA; James PA; du Sart D; Taylor AJ Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1108-16. PubMed ID: 24819852 [TBL] [Abstract][Full Text] [Related]
15. Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathy. Conte MR; Bongioanni S; Chiribiri A; Leuzzi S; Lardone E; Di Donna P; Pizzuti A; Luceri S; Cesarani F; Mabritto B; Zoccai GB; Bonamini R; Gaita F Am Heart J; 2011 Jun; 161(6):1073-7. PubMed ID: 21641353 [TBL] [Abstract][Full Text] [Related]
16. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy. Haland TF; Almaas VM; Hasselberg NE; Saberniak J; Leren IS; Hopp E; Edvardsen T; Haugaa KH Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):613-21. PubMed ID: 26873460 [TBL] [Abstract][Full Text] [Related]
17. Correlation of left ventricular dyssynchrony on gated myocardial perfusion SPECT analysis with extent of late gadolinium enhancement on cardiac magnetic resonance imaging in hypertrophic cardiomyopathy. Yuki H; Utsunomiya D; Shiraishi S; Takashio S; Sakamoto F; Tsuda N; Oda S; Kidoh M; Nakaura T; Tsujita K; Yamashita Y Heart Vessels; 2018 Jun; 33(6):623-629. PubMed ID: 29230571 [TBL] [Abstract][Full Text] [Related]
18. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy. Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014 [TBL] [Abstract][Full Text] [Related]
19. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047 [TBL] [Abstract][Full Text] [Related]
20. Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy: Implications for ventricular tachycardia ablation. Xie S; Desjardins B; Kubala M; Liang J; Yang J; van der Geest RJ; Schaller R; Riley M; Callans D; Zado E; Marchlinski F; Nazarian S Heart Rhythm; 2018 Jul; 15(7):987-993. PubMed ID: 29501666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]